Take-Away Points
■ Major Focus: Meta-analysis to evaluate supplemental screening modalities in women at average or intermediate risk for breast cancer with dense breasts and negative mammography.
■ Key Result: MRI demonstrated superior breast cancer detection rates compared with handheld US (HHUS), automated breast US (ABUS), and digital breast tomosynthesis (DBT).
■ Impact: Breast MRI is the most sensitive modality for supplemental screening in women with average or intermediate breast cancer risk and dense breasts, supporting further studies to assess overall benefits in clinical workflow.
Mammography, the primary imaging modality for breast cancer screening among asymptomatic women at average risk, remains the only modality proven to reduce breast cancer mortality in randomized controlled trials. However, mammographic sensitivity declines with increasing breast density, an independent risk factor for breast cancer development.
Supplemental screening techniques that partially or completely overcome the problem of dense breast tissue, including DBT, HHUS, ABUS, and breast MRI, have been shown to detect mammographically occult breast cancers. Interest in supplemental screening for dense breasts has risen steadily over the past decade due to breast density notification laws at state and federal levels requiring breast imaging centers to notify patients if they have dense breasts to allow informed decision-making regarding screening options. Despite this trend, few clinical guidelines exist regarding supplemental screening based on breast density alone. This is in part due to a paucity of evidence regarding the comparative performance of available techniques.
In this systematic review and meta-analysis, Hussein and Abbas et al compared performance of supplemental screening modalities in average- and intermediate-risk women with dense breasts and negative mammography. After screening 4663 abstracts from a literature search, the authors identified a total of 22 studies reporting 261 233 screened patients. The authors evaluated the incremental cancer detection rate (CDR), positive predictive values (PPV) of recall and biopsies performed, and interval cancer rate for each supplemental modality. A subset of 132 166 women met inclusion criteria with dense breasts and a negative mammogram. Within the study group, a total of 541 cancers were detected only with supplemental imaging. MRI showed the greatest incremental CDR (25.7 cancers per 1000 screenings) as compared with other modalities (HHUS, 4.3; ABUS, 4.3; DBT, 4.8). Metaregression showed a higher incremental CDR for MRI relative to mammography (1.54 per 1000 screenings; 95% CI: 0.74, 2.33; P < .001), including invasive CDR (1.31; 95% CI: 0.57, 2.06; P < .001) and in situ CDR (1.91; 95% CI: 0.10, 3.72; P < .04). Other modalities did not differ. Furthermore, MRI detected the smallest tumor size with negative node involvement (mean size, 9.5 mm) compared with other modalities (HHUS, 11.83 mm; ABUS, 16.3 mm; DBT, 13.0 mm). PPV of recall or biopsies showed no differences across modalities. Limited sample size precluded assessment of interval cancer rate.
Although MRI is recommended as an adjunct to screening mammography in patients at high risk for breast cancer, this meta-analysis suggests that MRI is also the most sensitive supplemental screening modality in average- or intermediate-risk women with dense breasts and negative mammograms, including those with a personal history of breast cancer. Further studies, including cost-effectiveness analyses and assessments of impact of MRI on mortality reduction, are needed to evaluate the overall benefit of MRI before it can be routinely recommended for supplemental screening in a lower-risk population.
Highlighted Article
Hussein H, Abbas E, Keshavarzi S, et al. Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis. Radiology 2023;306(3):e221785.
Highlighted Article
- Hussein H , Abbas E , Keshavarzi S , et al . Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis . Radiology 2023. ; 306 ( 3 ): e221785 . [DOI] [PubMed] [Google Scholar]
